OpenVSafe by OpenVAERS
Search V-safe

FPD-93462-83720

3 vaccinations 10 coded responses 21 check-ins 10 free-text entries 2 call cases
Sex
Male
Age at first dose
31-35
ZIP prefix
786 / TX
Registered
2021-01-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-08
    Dose 1 — Moderna
  2. 2021-01-10
    Registered in v-safe
  3. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  4. 2021-01-10
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-01-15
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-22
    Survey response — day 14, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Swollen gland in armpit near injecrion site.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-29
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-02-05
    Survey response — day 28, dose 1
    MedDRA: Lymphadenopathy, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Axillary lymphadenopathy ipsilateral of the arm in which I which I got the shot persists. · Healthcare visit (other): I am having a biopsy this coming Tuesday.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-05
    Report sent to call center — day 28, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-02-12
    Dose 2 — Moderna
  11. 2021-02-12
    Survey response — day 0, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain
    Free text: Axillary lymphadenopathy persists since January 20
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Headache · Be unable to work
    Adult check-in
  14. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Axillary lymphadenopathy persists
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Axillary lymphadenopathy persists
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-19
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Axillary lymphadenopathy persists
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-28
    Survey response — day 14, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: UNILATERAL axillary lymphadenopathy persists.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-05
    Survey response — day 21, dose 2
    MedDRA: Axillary lymphadenectomy — Feeling: Good
    Free text: UNILATERAL axillary lymphadenopathy persists
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-03-12
    Survey response — day 28, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Unilateral axillary lymphadenopathy persists.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-29
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-26
  24. 2021-08-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2022-10-05
    Dose 3 — Pfizer-BioNTech
  26. 2022-10-11
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Generalized lymphadenopathy in axillary of injection site
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-10-12
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2022-10-19
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-08Moderna
22021-02-12Moderna
32022-10-05Pfizer-BioNTech No

Call center

2 call center cases

1 unsuccessful · 1 priority 2/3 (triaged and no follow up)

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — day 14, dose 1

2021-01-22

Symptoms: Swollen gland in armpit near injecrion site.

Release 3 — day 28, dose 1

2021-02-05

Symptoms: Axillary lymphadenopathy ipsilateral of the arm in which I which I got the shot persists.
Healthcare visit (other): I am having a biopsy this coming Tuesday.

Release 4 — day 0, dose 2

2021-02-12

Systemic reaction (other): Axillary lymphadenopathy persists since January 20

Release 4 — days 1–6 daily, dose 2

2021-02-16

Systemic reaction (other): Axillary lymphadenopathy persists

2021-02-18

Systemic reaction (other): Axillary lymphadenopathy persists

Release 4 — day 7, dose 2

2021-02-19

Systemic reaction (other): Axillary lymphadenopathy persists

Release 4 — day 14, dose 2

2021-02-28

Symptoms: UNILATERAL axillary lymphadenopathy persists.

Release 5 — day 21, dose 2

2021-03-05

Symptoms: UNILATERAL axillary lymphadenopathy persists

Release 5 — day 28, dose 2

2021-03-12

Symptoms: Unilateral axillary lymphadenopathy persists.

Release 12 — days 1–6 daily, dose 3

2022-10-11

Systemic reaction (other): Generalized lymphadenopathy in axillary of injection site

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDAxillary lymphadenectomy ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release